Coming in the Air: Hypoxia Meets Epigenetics in Pancreatic Cancer

With a five-year survival rate under 9%, pancreatic ductal adenocarcinoma (PDAC) represents one of the deadliest tumors. Although the treatment options are slightly improving, PDAC is the second leading cause of cancer related death in 2020 in the US. In addition to a pronounced desmoplastic stroma...

Descripción completa

Detalles Bibliográficos
Autores principales: Geismann, Claudia, Arlt, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694089/
https://www.ncbi.nlm.nih.gov/pubmed/33113836
http://dx.doi.org/10.3390/cells9112353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694089/
https://www.ncbi.nlm.nih.gov/pubmed/33113836
http://dx.doi.org/10.3390/cells9112353

Ejemplares similares